Loperamide Hydrochloride
- Product NDC
- 66336-046
- 11-digit product format
- 663360046
- Labeler code
- 66336
- Product ID
- 66336-046_f9d114cb-c8ad-4660-ba45-4c08e60839d0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Loperamide Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Dispensing Solutions, Inc.
- Application
- ANDA073192
- Marketing category
- ANDA
- Marketing start
- 2011-09-23
- Marketing end
- 0000-00-00
- Substance
- LOPERAMIDE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Opioid Agonist [EPC],Opioid Agonists [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66336-046-02 | Loperamide Hydrochloride | 2 in 1 BOTTLE | CAPSULE | 2 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66336-046 | LOPERAMIDE HYDROCHLORIDE CAPSULE [DISPENSING SOLUTIONS, INC.] | 3 | Legacy NDC, 1 package rows | 20121004_3d23f73b-afc2-448d-afb3-b167d02cfc06.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 66336-046-02 | 66336004602 | 2 in 1 BOTTLE | Historical |